It has been established that ELAVL1 is up-regulated and associated with unfavorable outcomes in various cancer types, including lung cancer, ovarian cancer, pancreatic cancer, meningioma, esophageal squamous cell carcinoma, gastric cancer, and bladder cancer [28, 46, 48]. This evidence concerns the gene ELAVL1 and lung carcinoma.